Management of glioblastoma after recurrence : a changing paradigm

Abstract EN

Glioblastoma remains the most common primary brain tumor after the age of 40 years.

Maximal safe surgery followed by adjuvant chemoradiotherapy has remained the standard treatment for glioblastoma (GBM).

But recurrence is an inevitable event in the natural history of GBM with most patients experiencing it after 6–9 months of primary treatment.

Recurrent GBM poses great challenge to manage with no well-defined management protocols.

The challenge starts from differentiating radiation necrosis from true local progression.

A fine balance needs to be maintained on improving survival and assuring a better quality of life.

Treatment options are limited and ranges from re-excision, re-irradiation, systemic chemotherapy or a combination of these.

Re-excision and re-irradiation must be attempted in selected patients and has been shown to improve survival outcomes.

To facilitate the management of GBM recurrences, a treatment algorithm is proposed.